Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study. - Hansen DK; Dima D; Mian H; Devos J; Brazauskas R; Oloyede T; Afrough A; Ahmed N; Anderson L; Banerjee R; Berdeja JG; Bidikian A; et al. (Blood cancer journal, 2026)